NCT06939257View on ClinicalTrials.gov

The Impact of Gender Affirming Hormone Therapy on Pain In Gender Minority Adults

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

September 16, 2029

Study Completion Date

September 16, 2029

Conditions
PainGender Minority Individuals
Trial Locations (1)

66160

RECRUITING

The University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Kansas Medical Center

OTHER